Wegovy Pill for Women Over 50: What to Know at Menopause

Quick answer: Yes, women over 50 can be prescribed it. The Wegovy pill is a once-daily semaglutide tablet that FDA approved on December 22, 2025, for adults with obesity, or overweight plus a weight-related condition. ^{2 1} It isn't a menopause treatment, and its strict morning routine matters if you also take thyroid or HRT pills. ^{1 4}

Say you're 52 and your periods stopped last year. Your waistband feels tighter even though you eat the way you always have, and a friend just told you there's a Wegovy pill now, so you can skip the shots. You want to know if that pill was made for someone like you, before you bring it up at your next visit.

That question makes sense. Many women gain weight around menopause, ⁶ and The Menopause Society says about one in five women aged 50 to 64 report current or past use of a GLP-1 medicine. ⁹ You're far from the only one asking.

This guide reads the US Wegovy label through a midlife lens. You'll learn who was in the tablet trial and how the morning routine works with other pills. You'll also see what the label says about age, bones and the gallbladder, and how HRT and Medicare fit in. Every fact comes from FDA, Medicare.gov, NIDDK, The Menopause Society or published research.

Key takeaways

• The Wegovy pill is taken once a day on an empty stomach in the morning with up to 4 ounces of plain water. ¹ Then you wait at least 30 minutes before food, drinks or other pills. ¹
• In the 64-week tablet trial, the average participant was 48 and 79% were women, so midlife women were well represented. ¹
• Semaglutide tablets raised levothyroxine exposure by 33% in a drug study, so thyroid pill timing and monitoring are worth raising with your prescriber. ¹
• The Wegovy pill isn't hormone therapy and doesn't treat hot flashes; early studies link HRT use to better GLP-1 weight loss, but they can't prove cause. ^{4 5 9}
• If you're on Medicare and qualify, the GLP-1 Bridge has covered the Wegovy tablet since July 1, 2026, for a $50 monthly copay. ³

A pill you take every morning is easier to keep straight with a simple record. Mirvae: Perimenopause & GLP-1 is our own iOS app, free to download, with daily check-ins and symptom and medication journals, including a dedicated GLP-1 companion.

What the Wegovy pill is, and who it's approved for

The Wegovy pill is a tablet form of semaglutide, the same medicine in Wegovy injections, taken by mouth once a day. ¹ FDA approved Wegovy tablets on December 22, 2025. ²

The label lists two uses for the tablets, each alongside a reduced-calorie diet and more physical activity. ¹

• To reduce excess body weight and keep it off long term in adults with obesity, or adults with overweight and at least one weight-related condition. ¹
• To lower the risk of major heart events, such as heart attack or stroke, in adults with established heart disease and obesity or overweight. ¹

There's no upper age limit in that wording. Being over 50, or past menopause, doesn't make you eligible or ineligible on its own. Your prescriber looks at your weight, your other health conditions and your full medicine list. ⁸

The label also says not to combine Wegovy with other semaglutide products or any other GLP-1 medicine. ¹ It carries a boxed warning about thyroid C-cell tumors seen in rodents and shouldn't be used if you or a family member has had medullary thyroid cancer or MEN 2. ¹

Who was in the Wegovy tablet trial

The Wegovy tablet trial in the label looks a lot like a midlife waiting room. Study 7 ran 64 weeks and enrolled 307 adults with obesity, or overweight plus a condition such as high blood pressure or high cholesterol. ¹ Their average age was 48, and 79% were women. ¹ People with type 2 diabetes were left out. ¹

These are average trial results for the top tablet strength, observed in that study, not a prediction for any one person. Everyone in the trial also had diet and activity counseling. ¹

What the label says about age

In the tablet trial, 16 people taking the tablets (8%) were 65 to 74, and 5 (2%) were 75 or older. ¹ Across Wegovy studies, the label reports no overall difference in effectiveness between people 65 and older and younger adults. ¹ In the heart outcomes trial, people 75 and older on Wegovy injections reported more hip and pelvis fractures than those on placebo. ¹ That trial used the injection, but it's a fair reason to talk about bone health if you're older.

What causes weight change around 50, and where the pill fits

Weight change around 50 comes mostly from aging, with menopause shifting where fat is stored. The Menopause Society says aging is the primary driver of midlife weight gain, while falling estrogen tends to move fat toward the abdomen. ⁴ Women also lose about 3% to 8% of muscle per decade after 30, which lowers the calories burned at rest. ⁴

A large NIH-funded study of midlife women, SWAN, found that the rate of fat gain doubled at the start of the menopause transition while lean mass declined. ⁷ Total weight kept rising at a steady pace rather than speeding up. ⁷ So the scale may not tell the whole story; your shape and strength can change even when your weight barely does.

The Wegovy pill works on appetite and food intake through GLP-1 signaling. ¹ It doesn't replace estrogen, so it won't treat hot flashes, night sweats or vaginal dryness. Hormone therapy remains the standard treatment for hot flashes, says The Menopause Society, though it isn't a weight-loss treatment. ⁴ Our guide to perimenopause weight gain and belly fat covers the midlife changes in more depth.

The morning routine, and why it matters for your other pills

The Wegovy pill has a stricter routine than a weekly shot, and that's the part most women over 50 need to plan around. The label says to take it in the morning on an empty stomach, with up to 4 ounces of plain water and no other liquids. ¹ Swallow it whole, then wait at least 30 minutes before eating, drinking or taking any other oral medicine. ¹

Many women in their 50s already take something first thing in the morning. That's why this routine can collide with your current pills.

Don't reshuffle your routine on your own. Your prescriber and pharmacist can map out timing for every pill you take. For a side-by-side of the two GLP-1 pills and weekly shots, see our Foundayo vs Wegovy pill vs injections comparison.

Wegovy pill and HRT: what studies have found

Research on the Wegovy pill and HRT together is early, and the studies below don't report results for the tablet on its own. A small Mayo Clinic study of semaglutide in postmenopausal women found that the 16 women using hormone therapy lost more weight at 12 months than the 90 who weren't: 16% versus 12%. ⁵ The authors called for larger studies. ⁵

In October 2026, The Menopause Society reported a larger real-world study of nearly 2,400 women over 45 taking semaglutide. ⁹ Hormone therapy use was linked to greater and sustained weight loss. ⁹ The lead author still cautioned that it's too early for firm conclusions, and that weight loss isn't an indication for menopause hormone therapy. ⁹

So if you're already on HRT, that's useful context, not a plan. If you're weighing HRT for hot flashes, decide that on its own merits with your clinician. Our HRT and GLP-1 weight loss guide breaks down the 2026 study.

What's normal on the Wegovy pill, and what's not

Stomach side effects top the list of common Wegovy pill side effects. The Medication Guide lists nausea, stomach pain, diarrhea, constipation, vomiting, bloating, belching, gas, headache, tiredness and dizziness among the most common side effects. ¹

What's not normal, and needs a call, includes the following. ¹

• Severe stomach pain that won't go away, with or without vomiting, sometimes felt through to the back. Call your provider right away.
• Upper stomach pain, yellowing of the skin or eyes, fever or clay-colored stools, which can signal gallbladder problems.
• Nausea, vomiting or diarrhea that won't stop, because losing fluids can harm the kidneys.
• A racing or pounding heartbeat at rest that lasts several minutes.

Gallbladder problems are worth knowing about in midlife. In weight trials, gallstones were reported by 1.6% of adults on Wegovy injections versus 0.7% on placebo. ¹ Our GLP-1 gallbladder symptoms guide lists what to report.

Bone and muscle after 50

Bone and muscle deserve attention when you lose weight after menopause. Hormone therapy helps prevent bone loss, says the Office on Women's Health. ⁶ NIDDK and federal guidelines recommend at least 2 days a week of muscle-strengthening activity along with 150 minutes of moderate activity. ⁸ Our bone health questions for GLP-1 users can help you plan that conversation.

Pregnancy, perimenopause and planning ahead

Pregnancy is still possible in perimenopause, so the Wegovy pill's pregnancy guidance matters for some women in their late 40s and early 50s. The label says Wegovy may harm an unborn baby and gives specific timing advice for anyone planning a pregnancy, because semaglutide stays in the body a long time. ¹ Breastfeeding isn't recommended while taking the tablets. ¹ If there's any chance of pregnancy, raise it before your first prescription.

Medicare and the Wegovy pill

The Wegovy pill is one of three GLP-1 drugs Medicare covers under the temporary GLP-1 Bridge, which started July 1, 2026. ³ If you're eligible and have Medicare drug coverage, the copay is $50 a month. ³

Eligibility depends on your BMI and certain conditions, such as prediabetes, a past heart attack or stroke, or uncontrolled high blood pressure. ³ People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease aren't eligible for the Bridge, though their Part D plan might cover a GLP-1. ³ Your provider must certify you're in a diet and exercise program, and a prior authorization stays valid through December 31, 2027, unless your GLP-1 drug changes. ³ Our Medicare GLP-1 Bridge eligibility checklist walks through each rule.

Not on Medicare yet? Some, but not all, insurance plans cover weight medicines, so call yours before you assume either way. ⁸

What to do before you ask about the Wegovy pill: a 5-step plan

Use these steps to walk into your appointment with what your prescriber needs.

1. Write down every pill you take in the morning, including thyroid, HRT, birth control and supplements.
2. Note your menopause status: still having periods, irregular, or no period for 12 months.
3. List any history of thyroid cancer, pancreatitis, gallbladder or kidney problems. ¹
4. Check your coverage: Medicare Bridge rules or your plan's weight-medicine policy. ^{3 8}
5. Bring your questions about bones, muscle and a strength routine. ⁸

Before your appointment

Before your appointment, track two weeks of mornings: what time you wake, what you take and when you first eat or drink. That simple record shows your prescriber whether a 30-minute wait is realistic for you. ¹

Mirvae: Perimenopause & GLP-1 keeps those notes on your device, with no account needed. You can note your morning routine, symptoms such as hot flashes or nausea, and how you slept in your journals, then show them at your visit.

When to see a doctor

Talk with your prescriber before starting the Wegovy pill and about any side effect that's severe or won't go away. ¹ Tell every provider you take it before any surgery or procedure with anesthesia or deep sedation. ¹ Call your provider right away for severe stomach pain that won't go away. ¹ Get medical help right away, or call 911, for swelling of your face, lips, tongue or throat, trouble breathing or swallowing, fainting, or a very rapid heartbeat. ¹

How to track this in Mirvae

Mirvae: Perimenopause & GLP-1 is our own iOS app. It's free to download, and it has daily check-ins for sleep, energy, mood and stress, plus symptom and medication journals, including a dedicated GLP-1 companion. Your records stay on your device. It's a wellness tool, not a medical device, and it doesn't prescribe or sell medicine.

Part of our GLP-1 Medications: Ozempic, Wegovy, Zepbound & More guide.

FAQ

Can women over 50 take the Wegovy pill? Yes, if a prescriber decides it fits. The label has no upper age limit and covers adults with obesity, or overweight plus a weight-related condition. ¹

Does the Wegovy pill help with menopause symptoms? No. It's a weight and heart-risk medicine, not hormone therapy. Hormone therapy remains the standard treatment for hot flashes. ⁴

Can I take the Wegovy pill with HRT? The label doesn't list HRT as off-limits, but it says semaglutide may affect how oral medicines are absorbed. ¹ Ask your prescriber how to time both.

Can I take the Wegovy pill with my thyroid medicine? Ask first. A semaglutide tablet raised levothyroxine exposure by 33% in a drug study, and the label advises monitoring. ¹

When should I take the Wegovy pill? Take it in the morning on an empty stomach with up to 4 ounces of water. ¹ Then wait at least 30 minutes before food, drinks or other pills. ¹

Does Medicare cover the Wegovy pill? Under the GLP-1 Bridge, Medicare covers the Wegovy tablet for a $50 monthly copay if you're eligible. ³

Is the Wegovy pill the same as Foundayo? No. The Wegovy pill is semaglutide from Novo Nordisk. ² Foundayo is orforglipron, a different medicine FDA approved for Eli Lilly on April 1, 2026. ¹⁰ Our Foundayo vs Wegovy pill vs injections comparison explains how they differ.

Will I regain weight if I stop? NIDDK says you'll probably regain some weight after stopping a weight medicine, and healthy habits may help you regain less. ⁸

Related guides

Mirvae tracker: write down tomorrow's morning routine, minute by minute. If you'd like your pills, symptoms and notes in one place, download Mirvae: Perimenopause & GLP-1 free on the App Store.

• Foundayo vs Wegovy pill vs injections
• Medicare GLP-1 Bridge checklist
• Contrave vs Wegovy: Naltrexone-Bupropion or Semaglutide?.
• Semaglutide vs Tirzepatide: What the Direct Trial Found.
• Trulicity vs Ozempic: Which Works Better, and for Whom?.
• Stopping a GLP-1: Weight Regain, What Happens, What to Ask.

Sources

• C1. Wegovy prescribing information and Medication Guide (injection and tablets), DailyMed, revised 6/2026. Revised 6/2026; checked 2026-11-09.
• C2. FDA approval letter for Wegovy (semaglutide) tablets, NDA 218316, dated December 22, 2025, Novo Nordisk. Dated 2025-12-22; checked 2026-11-09.
• C3. Medicare.gov Weight loss drugs. Checked 2026-11-09.
• C4. The Menopause Society MenoNote. 2025; checked 2026-11-09.
• C5. Hurtado et al., Menopause 2024 (PMID 38446869). Published 2024-03-05; abstract verified via ncbi e-utilities; checked 2026-11-09.
• C6. Office on Women's Health, Menopause and your health. Page updated 2026-10-19; checked 2026-11-09.
• C7. Greendale et al., JCI Insight 2019, SWAN DXA study. 2019; checked 2026-11-09.
• C8. NIDDK Prescription Medications to Treat Overweight and Obesity. Last reviewed june 2024; checked 2026-11-09.
• C9. The Menopause Society press release, October 20, 2026. Dated 2026-10-20; checked 2026-11-09.
• C10. FDA press announcement, April 1, 2026. Dated 2026-04-01; checked 2026-11-09.

About this page

Mirvae: Perimenopause & GLP-1 is a wellness tool, not a medical device, and does not replace professional care.

Written with AI assistance by the Mirvae Editorial Team. Reviewer: NOT ASSIGNED. Educational content only, not medical advice. Talk with a qualified clinician about your own care. Mirvae does not prescribe or sell medication and is not affiliated with Novo Nordisk or Medicare. In an emergency, call 911.